http://glassdoor.com/slink.htm?key=vQXq1
Jan. 3, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:30 am PT, or 11:30 am ET, in San Francisco, California .
http://glassdoor.com/slink.htm?key=vIhPU
BioMarin became one of the world's most valuable biotechs by jettisoning costly distractions and focusing on one thing: treating some of the rarest diseases on the planet.
At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options, and are usually ignored.
Time is critical to patients with rare diseases, and we strive to quickly develop important therapies for them. The efficiency and speed of our research, development, manufacturing, and commercial efforts is at the heart of our ability to urgently deliver therapies. Our track record of developing and commercializing new treatments has been significantly faster than the industry average and is ingrained in our culture. CenterWatch, a leading source for global clinical trial information, has named it one of the fastest drug developers in the industry. BioMarin was also ranked tenth on Forbes list of innovative companies in 2015.
As a biopharmaceutical company, our success stems from our focus on science and the hope our therapies can bring to patients. We are world leaders in metabolic disease innovation with multiple products commercialized and a growing pipeline of product candidates to address unmet medical needs. We continue to fuel our R&D engine by looking for opportunities that align with our strengths and competencies. And we relentlessly pursue exciting, early-stage science that has the potential to change the course of disease.
A constant in BioMarin’s culture is how patients continue to drive us. The passion and dedication that our employees bring to work each day is a testament to the inspiration our patients provide, and the knowledge of the impact we can make in their lives.
PROMISING FUTURES.
What makes working here unique? At BioMarin, we feel the intense tie between the work we do and the life-changing results it delivers. Our focus on rare disease gives us the rare opportunity to truly impact lives.
As employees, we’re here because we want to be here. We enjoy our work — and each other. Our people are smart. Unassuming. Collaborative. Curious. Interesting. We share a passion for shared accomplishment — across teams and across borders — and are committed to our people, our purpose, and most of all, our patients. This common ground elevates the impact each of us is able to make every single day.
Our appetite for science drives us. Our team members motivate us. And our patients inspire us. Together we’re growing a company unlike any other, because our motivation is unlike any other.
At BioMarin, we’re inspired, driven, and empowered by the patients who benefit from our therapies. Continually fueling our R&D engine, we look for opportunities to develop first-in-class and best-in-class therapeutics to make a meaningful impact on the lives of those with rare genetic diseases.
RESEARCH & DEVELOPMENT
From research and discovery to post-market clinical development, our R&D engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with rare diseases.
TECHNICAL OPERATIONS
Our manufacturing and process development teams manage the production of our therapies for clinical trials and commercial markets. These engineers, technicians, scientists, and support professionals continually provide quality assurance and ensure we meet all regulatory standards. We have manufacturing facilities in Northern California and in Cork, Ireland. Additionally, our supply chain teams procure the goods and services needed to support manufacturing and worldwide distribution.
COMMERCIAL & MARKETING
Be part of the worldwide infrastructure that gets our drugs to underserved patients around the world. Our global sales force solidifies BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as South America, EuMEA, and Asia-Pacific.
GENERAL & ADMINISTRATIVE
It takes a village, and at BioMarin, our general and admin teams are the village behind our success. From the IT experts who manage our technology to the human resources professionals who hire the people who make it all possible, these teams support our organization and span all areas of operations.
What do you enjoy most about working at BioMarin? The scientific approach. At BioMarin, we look at the science behind things and justify what we do from there. It’s unique, and it’s exciting. Our orphan drug status means that our timelines are very short comparatively. It’s also very patient-focused. Management makes a big effort to make sure we, as employees, are aware of our patients’ stories — that we know who we are working for, which is really motivating. There is also a high caliber of people here. We need people with diverse backgrounds — in education and beyond — to address the need for different product aspects.
Do you see BioMarin as a leader? How so? I would say BioMarin is a leader in innovation. We operate under a different model — we’re not trying to replicate big pharma. We deliver orphan drugs, which means our timeline to market is much faster than at many biopharm companies. This is also a place where, if you have an idea about how something might be done better — there is a forum for your ideas to be heard. We all work together with one goal in mind, and it makes us all really feel like true contributors. We’re working on a lot of new, pioneering technology — things that have never been done before. Gene therapy is exciting and potentially groundbreaking. It takes a lot of courage to be a leader in new technologies, and I think we do it successfully at BioMarin.
What should candidates know about BioMarin? BioMarin is at a really great, fantastic stage. It’s big enough that we’re not a startup, but not so big that there isn’t room to have a strong and important impact on our future. The company has more than doubled in the past year, and with tremendous growth comes opportunity. Beyond that, BioMarin is just a great company to work for, and the work you do is both challenging and fulfilling. I feel that I have a lot of impact on the products I work on, testing, information in submissions, the manufacturing processes themselves. I do not feel that this level of personal influence would be the same at a larger company. It’s very rewarding.
Helpful (6)
I have been working at BioMarin Pharmaceutical full-time (More than 3 years)
Pros
Excellent benefits, including generous vacation and holiday policy. Modern offices in downtown San Rafael. Free parking and close to public transportation. Proximity to San Francisco.
Cons
Some departments exhibit larger than average employee turn-over rate.
Advice to Management
Spend more time and resources bringing existing employees up the ranks rather than hiring from the outside.
Application
I applied online. I interviewed at BioMarin Pharmaceutical.
Interview
Applied online and got both phone and onsite interviews. The interview questions were very straightforward. The whole process took about a month. People are very nice and friendly, they have such great team.
Interview Questions
